ROCHE HOLDINGS AG SPN ADR EACH REP 0.125 GENUS revenue for the last year amounted to 68.15 B USD, the most of which — 51.50 B USD — came from its highest performing source at the moment, Pharmaceuticals, the year earlier bringing 50.92 B USD. The greatest contribution to the revenue figure was made by United States — last year it brought ROCHE HOLDINGS AG SPN ADR EACH REP 0.125 GENUS 31.55 B USD, and the year before that — 30.69 B USD.